eXoZymes CEO to Discuss Commercialization in Fireside Chat
News related to:eXoZymes · 2 min read
LOS ANGELES, October 21, 2026 /CourierPR/ -- eXoZymes Inc., a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines, announced that Chief Executive Officer, Michael Heltzen, will participate in a fireside chat hosted by Water Tower Research ("WTR") on October 22, 2026, at 11:00 AM Eastern Time / 8:00 AM Pacific Time. The event is open to institutional and retail investors, as well as other interested parties. The fireside chat will focus on how eXoZymes intends to translate its cell-free biomanufacturing technology into commercial opportunities, beginning with NCT, a rare naturally occurring molecule being developed for nutraceutical applications and longer-term pharmaceutical opportunities.
The discussion will delve into eXoZymes' strategy for commercializing its technology, including the manufacturing economics of NCT and recent productivity improvements. It will also explore the company's plans for scaling production and bringing products to market, with a particular emphasis on its NCT-focused subsidiary, NCTx. Additionally, the fireside chat will address potential revenue streams and competitive positioning, as well as funding considerations and opportunities to apply the platform to additional molecules, including rare cannabinoids.
The event, which is expected to offer insights into key milestones and potential catalysts over the next 12 months, will be a valuable opportunity for investors to hear directly from eXoZymes' CEO about the company's commercialization strategy, business model, and growth opportunities. The fireside chat is scheduled for October 22, 2026, at 11:00 AM Eastern Time / 8:00 AM Pacific Time.
Founded in 2019, eXoZymes is pioneering a cell-free biomanufacturing platform that uses AI-enhanced enzymes, called exozymes, to make valuable natural products and new analogs outside living cells. The company's platform is designed to replace inefficient extraction and petrochemical processes with a scalable way to produce high-value molecules for nutraceutical and pharmaceutical markets.
The fireside chat is moderated by Robert Sassoon, Managing Director of Healthcare, Emerging Growth & Special Situations at WTR. The event is open to institutional and retail investors, as well as other interested parties. Advance registration is encouraged.
eXoZymes contact information: Lasse Görlitz, VP of Communications & IR (858) 319-7135 press@exozymes.